{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T04:15:10Z","timestamp":1743308110504,"version":"3.40.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10096-024-05035-y","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T23:28:31Z","timestamp":1738538911000},"page":"877-886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study"],"prefix":"10.1007","volume":"44","author":[{"given":"Matthieu","family":"Holub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lebeaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Grohs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Pellerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Cheminet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najiby","family":"Kassis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salom\u00e9","family":"Abdellaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Pouchot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Ranque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Benoit","family":"Arlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Lafont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"key":"5035_CR1","unstructured":"SPF. Surveillance des infections associ\u00e9es aux dispositifs invasifs. Mission nationale SPIADI. R\u00e9sultats de la surveillance men\u00e9e en 2020 [Internet]. [cit\u00e9 7 mai 2024]. Disponible sur: https:\/\/www.santepubliquefrance.fr\/import\/surveillance-des-infections-associees-aux-dispositifs-invasifs.-mission-nationale-spiadi.-resultats-de-la-surveillance-menee-en-2020"},{"issue":"9","key":"5035_CR2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4065\/81.9.1159","volume":"81","author":"DG Maki","year":"2006","unstructured":"Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc sept 81(9):1159\u20131171","journal-title":"Mayo Clin Proc sept"},{"issue":"4","key":"5035_CR3","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","volume":"38","author":"KL Hassell","year":"2010","unstructured":"Hassell KL (2010) Population estimates of sickle cell disease in the US. Am J Prevent Med 38(4):S512-21","journal-title":"Am J Prevent Med"},{"issue":"2","key":"5035_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjh.12950","volume":"166","author":"V Brousse","year":"2014","unstructured":"Brousse V, Buffet P, Rees D (2014) The spleen and sickle cell disease: the sick(led) spleen. Br J Haematol Juill 166(2):165\u2013176","journal-title":"Br J Haematol Juill"},{"issue":"13","key":"5035_CR5","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","volume":"303","author":"DC Brousseau","year":"2010","unstructured":"Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA (2010) Acute care utilization and rehospitalizations for sickle cell disease. Jama 303(13):1288\u201394","journal-title":"Jama"},{"issue":"1","key":"5035_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","volume":"328","author":"PL Kavanagh","year":"2022","unstructured":"Kavanagh PL, Fasipe TA, Wun T (2022) Sickle Cell Disease: A Review. Jama 328(1):57\u201368","journal-title":"Jama"},{"issue":"2","key":"5035_CR7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajh.22230","volume":"87","author":"N Shah","year":"2012","unstructured":"Shah N, Landi D, Shah R, Rothman J, De Castro LM, Thornburg CD (2012) Complications of implantable venous access devices in patients with sickle cell disease. Am J Hematol 87(2):224\u2013226","journal-title":"Am J Hematol"},{"issue":"2","key":"5035_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajh.10047","volume":"69","author":"MR Jeng","year":"2002","unstructured":"Jeng MR, Feusner J, Skibola C, Vichinsky E (2002) Central venous catheter complications in sickle cell disease. Am J Hematol f\u00e9vr 69(2):103\u2013108","journal-title":"Am J Hematol f\u00e9vr"},{"issue":"1","key":"5035_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000197023.46846.1c","volume":"85","author":"V Zarrouk","year":"2006","unstructured":"Zarrouk V, Habibi A, Zahar JR, Roudot-Thoraval F, Bachir D, Brun-Buisson C, Legrand P, Godeau B, Galacteros F, Lesprit P (2006) Bloodstream Infection in Adults With Sickle Cell Disease: Association With Venous Catheters: Staphylococcus aureus: and Bone-Joint Infections. Medicine 85(1):43\u20138","journal-title":"Medicine"},{"issue":"4","key":"5035_CR10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.RVI.0000121410.46920.6E","volume":"15","author":"SC Wagner","year":"2004","unstructured":"Wagner SC, Eschelman DJ, Gonsalves CF, Bonn J, Sullivan KL (2004) Infectious complications of implantable venous access devices in patients with sickle cell disease. J Vasc Interv Radiol JVIR avr 15(4):375\u2013378","journal-title":"J Vasc Interv Radiol JVIR avr"},{"issue":"10","key":"5035_CR11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ajh.20692","volume":"81","author":"L Chulamokha","year":"2006","unstructured":"Chulamokha L, Scholand SJ, Riggio JM, Ballas SK, Horn D, DeSimone JA (2006) Bloodstream infections in hospitalized adults with sickle cell disease: A retrospective analysis. Am J Hematol 81(10):723\u2013728","journal-title":"Am J Hematol"},{"issue":"5","key":"5035_CR12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.08511109","volume":"5","author":"JP Haymann","year":"2010","unstructured":"Haymann JP, Stankovic K, Levy P, Avellino V, Tharaux PL, Letavernier E, Grateau G, Baud L, Girot R, Lionnet F (2010) Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol 5(5):756\u201361","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5035_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infect Dis 49(1):1\u201345","journal-title":"Clinical Infect Dis"},{"issue":"2","key":"5035_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1473-3099(13)70266-4","volume":"14","author":"D Lebeaux","year":"2014","unstructured":"Lebeaux D, Fern\u00e1ndez-Hidalgo N, Chauhan A, Lee S, Ghigo JM, Almirante B, Beloin C (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. The Lancet Infect Dis 14(2):146\u201359","journal-title":"The Lancet Infect Dis"},{"issue":"5","key":"5035_CR15","doi-asserted-by":"crossref","first-page":"106960","DOI":"10.1016\/j.ijantimicag.2023.106960","volume":"62","author":"E Senneville","year":"2023","unstructured":"Senneville E, Cuervo G, Gregoire M, Hidalgo-Tenorio C, Jehl F, Miro JM et al (2023) Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel. Int J Antimicrob Agents 62(5):106960","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"5035_CR16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MOH.0000000000000455","volume":"25","author":"MS Karafin","year":"2018","unstructured":"Karafin MS, Fu X, D\u2019Alessandro A, Thomas T, Hod EA, Zimring JC, Field JJ, Francis RO (2018) The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease. Current Opinion Hematol 25(6):494\u20139","journal-title":"Current Opinion Hematol"},{"key":"5035_CR17","unstructured":"PRIME PubMed | Prevalence and morbidity of G6PD deficiency in sickle cell disease in the homozygote. https:\/\/www.unboundmedicine.com\/medline\/citation\/16295757\/Prevalence_and_morbidity_of_G6PD_deficiency_in_sickle_cell_disease_in_the_homozygote. Accessed 7 May 2024"},{"issue":"7","key":"5035_CR18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00228-023-03500-9","volume":"79","author":"F Elbarbry","year":"2023","unstructured":"Elbarbry F, Moshirian N (2023) Linezolid-associated serotonin toxicity: a systematic review. Eur J Clin Pharmacol juill 79(7):875\u2013883","journal-title":"Eur J Clin Pharmacol juill"},{"issue":"5","key":"5035_CR19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/pathogens9050329","volume":"9","author":"VA Appiah","year":"2020","unstructured":"Appiah VA, Pesewu GA, Kotey FC, Boakye AN, Duodu S, Tette EM, Nyarko MY, Donkor ES (2020) Staphylococcus aureus Nasal Colonization among Children with Sickle Cell Disease at the Children\u2019s Hospital, Accra: Prevalence, Risk Factors, and Antibiotic Resistance. Pathogens 9(5):329","journal-title":"Pathogens"},{"issue":"1","key":"5035_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/idr13010022","volume":"13","author":"NT Dayie","year":"2021","unstructured":"Dayie NT, Sekoh DN, Kotey FC, Egyir B, Tetteh-Quarcoo PB, Adutwum-Ofosu KK, Ahenkorah J, Osei MM, Donkor ES (2021) Nasopharyngeal Carriage of Methicillin-Resistant Staphylococcus aureus (MRSA) among Sickle Cell Disease (SCD) Children in the Pneumococcal Conjugate Vaccine Era. Infectious Dis Rep 13(1):191\u2013204","journal-title":"Infectious Dis Rep"},{"key":"5035_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fmicb.2017.00217","volume":"8","author":"LC Rocha","year":"2017","unstructured":"Rocha LC, Carvalho MOS, Nascimento VML, Dos Santos MS, Barros TF, Adorno EV et al (2017) Nasopharyngeal and Oropharyngeal Colonization by Staphylococcus aureus and Streptococcus pneumoniae and Prognostic Markers in Children with Sickle Cell Disease from the Northeast of Brazil. Front Microbiol 8:217","journal-title":"Front Microbiol"},{"issue":"14","key":"5035_CR22","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.2023.17219","volume":"330","author":"SS Huang","year":"2023","unstructured":"Huang SS, Septimus EJ, Kleinman K, Heim LT, Moody JA, Avery TR, McLean L, Rashid S, Haffenreffer K, Shimelman L, Staub-Juergens W (2023) Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial. JAMA 330(14):1337\u201347","journal-title":"JAMA"},{"issue":"19","key":"5035_CR23","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMoa2215254","volume":"389","author":"LG Miller","year":"2023","unstructured":"Miller LG, McKinnell JA, Singh RD, Gussin GM, Kleinman K, Saavedra R, Mendez J, Catuna TD, Felix J, Chang J, Heim L (2023) Decolonization in Nursing Homes to Prevent Infection and Hospitalization. New England J Med 389(19):1766\u201377","journal-title":"New England J Med"},{"key":"5035_CR24","doi-asserted-by":"crossref","unstructured":"Ch van den B, J van W, Md van de W. Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer. Cochrane Database Syst Rev [Internet]. 10 juill 2021 [cit\u00e9 26 mars 2024];10(10). Disponible sur: https:\/\/pubmed.ncbi.nlm.nih.gov\/34617602\/","DOI":"10.1002\/14651858.CD003295.pub4"},{"key":"5035_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-019-2683-3","volume":"24","author":"N Buetti","year":"2020","unstructured":"Buetti N, Ruckly S, Schwebel C, Mimoz O, Souweine B, Lucet JC, Timsit JF (2020) Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better? Critical Care 24:1\u20138","journal-title":"Critical Care"},{"key":"5035_CR26","doi-asserted-by":"crossref","unstructured":"Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, Mihala G, Rickard CM. Dressings and securement devices for central venous catheters (CVC). Cochrane Database of Systematic Reviews. 2015(9).","DOI":"10.1002\/14651858.CD010367.pub2"},{"issue":"4","key":"5035_CR27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00043426-199511000-00011","volume":"17","author":"A Abdul-Rauf","year":"1995","unstructured":"Abdul-Rauf A, Gauderer M, Chiarucci K, Berman B (1995) Long-term central venous access in patients with sickle cell disease: incidence of thrombotic and infectious complications. J Pediat Hematol\/oncol 17(4):342\u20135","journal-title":"J Pediat Hematol\/oncol"},{"issue":"2","key":"5035_CR28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2257.1996.00154.x","volume":"18","author":"CE McCready","year":"1996","unstructured":"McCready CE, Doughty HA, Pearson TC (1996) Experience with the Port-A-Cath in sickle cell disease. Clin Lab Haematol juin 18(2):79\u201382","journal-title":"Clin Lab Haematol juin"},{"issue":"22","key":"5035_CR29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V114.22.1382.1382","volume":"114","author":"P Mollee","year":"2009","unstructured":"Mollee P, Jones M, Stackelroth J, van Kuilenburg R, Joubert W, Faoagali J, Looke D, Harper J, Clements A (2009) Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study. Blood. 114(22):1382","journal-title":"Blood."},{"issue":"8","key":"5035_CR30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/eci.12477","volume":"45","author":"J Rabensteiner","year":"2015","unstructured":"Rabensteiner J, Theiler G, Duettmann W, Zollner-Schwetz I, Hoenigl M, Valentin T et al (2015) Detection of central venous catheter-related bloodstream infections in haematooncological patients. Eur J Clin Invest ao\u00fbt 45(8):824\u2013832","journal-title":"Eur J Clin Invest ao\u00fbt"},{"issue":"3","key":"5035_CR31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1086\/501609","volume":"20","author":"MJ Sotir","year":"1999","unstructured":"Sotir MJ, Lewis C, Bisher EW, Ray SM, Soucie JM, Blumberg HM (1999) Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol mars 20(3):187\u2013191","journal-title":"Infect Control Hosp Epidemiol mars"},{"issue":"9","key":"5035_CR32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/INF.0000000000003177","volume":"40","author":"I Kristinsdottir","year":"2021","unstructured":"Kristinsdottir I, Haraldsson A, Gudlaugsson O, Thors V (2021) Low Risk of Central Line\u2013associated Bloodstream Infections in Pediatric Hematology\/Oncology Patients. Pediat Infect Dis J 40(9):827\u201331","journal-title":"Pediat Infect Dis J"},{"issue":"2","key":"5035_CR33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jinf.2017.10.014","volume":"76","author":"C Samuelson","year":"2018","unstructured":"Samuelson C, Kaur H, Kritsotakis EI, Goode SD, Nield A, Partridge D (2018) A daily topical decontamination regimen reduces catheter-related bloodstream infections in haematology patients. J Infect f\u00e9vr 76(2):132\u2013139","journal-title":"J Infect f\u00e9vr"},{"issue":"3","key":"5035_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08880018.2013.772683","volume":"30","author":"S Celebi","year":"2013","unstructured":"Celebi S, Sezgin ME, Cak\u0131r D, Baytan B, Demirkaya M, Sevinir B et al (2013) Catheter-associated bloodstream infections in pediatric hematology-oncology patients. Pediatr Hematol Oncol avr 30(3):187\u2013194","journal-title":"Pediatr Hematol Oncol avr"},{"key":"5035_CR35","unstructured":"O\u2019Grady NP. Prevention of Central Line\u2013Associated Bloodstream Infections. N Engl J Med [Internet]. 20 sept 2023 [cit\u00e9 8 oct 2023]; Disponible sur: https:\/\/www.nejm.org\/action\/showPdf"},{"issue":"5","key":"5035_CR36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/bjh.18548","volume":"200","author":"SO Ibemere","year":"2023","unstructured":"Ibemere SO, Oyedeji CI, Preiss L, Van Althuis LE, Hankins JS, Azul M et al (2023) Characterising the prevalence of overweight and obese status among adults with sickle cell disease. Br J Haematol mars 200(5):633\u2013642","journal-title":"Br J Haematol mars"},{"issue":"5","key":"5035_CR37","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/jac\/dkad083","volume":"78","author":"M Lafaurie","year":"2023","unstructured":"Lafaurie M, Montlahuc C, Kerneis S, De Lastours V, Abgrall S, Manceron V, Couzigou C, Chabrol A, De Raigniac A, Lescure X, Longuet P (2023) Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer. J Antimic Chemother 78(5):1253\u20138","journal-title":"J Antimic Chemother"},{"key":"5035_CR38","doi-asserted-by":"crossref","unstructured":"Albert O, Bonnet E, Cassard B, Chambrier C, Charmillon A, Diamantis S, et al. Antibiotic lock therapy for the conservative treatment of long-term intravenous catheter-related infections in adults and children: When and how to proceed? Guidelines for clinical practice 2020. Infect Dis Now. 1 mai 2021;51(3):236\u201146.","DOI":"10.1016\/j.idnow.2021.02.004"},{"issue":"9","key":"5035_CR39","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s00134-014-3403-8","volume":"40","author":"JJ De Waele","year":"2014","unstructured":"De Waele JJ, Lipman J, Akova M, Bassetti M, Dimopoulos G, Kaukonen M et al (2014) Risk factors for target non-attainment during empirical treatment with \u03b2-lactam antibiotics in critically ill patients. Intensive Care Med sept 40(9):1340\u20131351","journal-title":"Intensive Care Med sept"},{"issue":"9","key":"5035_CR40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneph.2011.92","volume":"7","author":"AA Udy","year":"2011","unstructured":"Udy AA, Roberts JA, Lipman J (2011) Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol 7(9):539\u201343","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"5035_CR41","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.3324\/haematol.2017.169128","volume":"102","author":"J Han","year":"2017","unstructured":"Han J, Zhang X, Oderinde J, Saraf SL, Gowhari M, Hassan J et al (2017) Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways. Haematologica ao\u00fbt 102(8):e282\u2013e284","journal-title":"Haematologica ao\u00fbt"},{"issue":"9","key":"5035_CR42","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jiac.2022.05.017","volume":"28","author":"A Al-Eyadhy","year":"2022","unstructured":"Al-Eyadhy A, Al-Jelaify MR (2022) Suboptimal vancomycin levels in critically ill children with sickle cell disease and acute chest syndrome. J Infect Chemother Off J Jpn Soc Chemother. 28(9):1304\u20139","journal-title":"J Infect Chemother Off J Jpn Soc Chemother."},{"key":"5035_CR43","doi-asserted-by":"crossref","unstructured":"Habibi A, Arlet JB, Stankovic K, Gellen-Dautremer J, Ribeil JA, Bartolucci P, et al. [French guidelines for the management of adult sickle cell disease: 2015 update]. Rev Med Interne. 11 mai 2015;36(5 Suppl 1):5S3\u201384","DOI":"10.1016\/S0248-8663(15)60002-9"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-05035-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-05035-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-05035-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T17:11:27Z","timestamp":1743268287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-05035-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,2]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5035"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-05035-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2025,2,2]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}